Multi-target neuroprotective effects of herbal medicines for Alzheimer's disease
Open accessAbstract
ETHNOPHARMACOLOGICAL RELEVANCE Alzheimer's disease is the most common form of dementia, but its treatment options remain few and ineffective. To find new therapeutic strategies, natural products have gained interest due to their neuroprotective potential, being able to target different pathological hallmarks associated with this disorder. Several plant species are traditionally used due to their empirical neuroprotective effects and it is worth to explore their mechanism of action. AIM OF THE STUDY This study intended to explore the neuroprotective potential and the safety in regard to pesticide residues of seven traditional medicinal plants, namely Scutellaria baicalensis, Ginkgo biloba, Hypericum perforatum, Curcuma longa, Lavandula angustifolia, Trigonella foenum-graecum and Rosmarinus officinalis. The safety assessment with reference to pesticides residues was also aimed. MATERIALS AND METHODS Decoctions prepared from these species were chemically characterized by HPLC-DAD and screened for their ability to scavenge four different free radicals (DPPH●, ABTS●+, O2●‒ and ●NO) and to inhibit enzymes related to neurodegeneration (cholinesterases and glycogen synthase kinase-3β). Cell viability through MTT assay was also evaluated in two different brain cell lines, namely non-tumorigenic D3 human brain endothelial cells (hCMEC/D3) and NSC-34 motor neurons. Furthermore, and using GC, 20 pesticides residues were screened. RESULTS Regarding chemical composition, chromatographic analysis revealed the presence of several flavonoids, phenolic acids, curcuminoids, phenolic diterpenoids, one alkaloid and one naphthodianthrone in the seven decoctions. All extracts were able to scavenge free radicals and were moderate glycogen synthase kinase-3β inhibitors; however, they displayed weak to moderate acetylcholinesterase and butyrylcholinesterase inhibition. G. biloba and L. angustifolia decoctions were the less cytotoxic to hCMEC/D3 and NSC-34 cell lines. No pesticides residues were detected. CONCLUSIONS The results extend the knowledge on the potential use of plant extracts to combat multifactorial disorders, giving new insights into therapeutic avenues for Alzheimer's disease.
AI snapshot
Written from the paper’s full text.
TL;DR
Seven traditional medicinal plant decoctions were chemically profiled and screened in vitro for antioxidant, cholinesterase, GSK-3β, cytotoxicity, and pesticide-residue effects relevant to Alzheimer’s disease. All extracts scavenged free radicals and inhibited GSK-3β by more than 60% at 4.2 μg/mL, but cholinesterase inhibition was weak to moderate and no pesticide residues were detected.
Key findings
- HPLC-DAD identified flavonoids, phenolic acids, curcuminoids, phenolic diterpenoids, trigonelline, and hypericin across the seven decoctions. Total phenolic content ranged from 29.00 ± 3.49 mg GAE/g extract dw for *T. foenum-graecum* to 327.31 ± 26.88 mg GAE/g extract dw for *R. officinalis*.
- *H. perforatum* and *R. officinalis* were the most potent DPPH• scavengers (100.01 ± 7.43 and 91.57 ± 9.16 mg GAE/g extract dw, respectively) and ABTS•+ scavengers (350.45 ± 10.55 and 282.94 ± 12.30 mg TE/g extract dw, respectively), while *C. longa* was weakest (22.54 ± 3.34 and 30.38 ± 1.96 TE/g extract dw). For O2•− and •NO, *R. officinalis* (IC50 = 53.65 and 121.33 μg/mL) and *H. perforatum* (IC50 = 59.34 and 151.25 μg/mL) were most active.
- AChE inhibition reached 50% only for *S. baicalensis* (IC50 = 796.55 μg/mL), *G. biloba* (IC50 = 2076.07 μg/mL), and *R. officinalis* (IC50 = 1068.44 μg/mL); BuChE inhibition was considerable only for *L. angustifolia* (IC50 = 2145.94 μg/mL) and *R. officinalis* (IC50 = 858.75 μg/mL). *R. officinalis* inhibited both cholinesterases non-competitively. All extracts showed >60% GSK-3β inhibition at 4.2 μg/mL, with *S. baicalensis* most potent (83.42 ± 2.99%).
- *G. biloba* and *L. angustifolia* were least cytotoxic to hCMEC/D3 and NSC-34 cells (IC50 > 1000 μg/mL). *T. foenum-graecum* was most toxic to NSC-34 (IC50 < 250 μg/mL), and *T. foenum-graecum*, *R. officinalis*, and *C. longa* markedly decreased hCMEC/D3 viability (IC50 < 250 μg/mL). No organochlorine or organophosphorus pesticide residues were detected among the 21 screened.
Methods
- Decoctions (n = 4) were prepared by boiling 0.5 g of ground commercial plant material in 125 mL water for 10 min, then filtering and lyophilizing; extraction yields ranged from 18.25 ± 0.63% (*C. longa*) to 47.17 ± 1.82% (*S. baicalensis*).
- Chemical characterization used Folin-Ciocalteu total phenolic content and HPLC-DAD with external calibration curves. Pesticide screening used SPE cleanup followed by GC for 21 organochlorine and organophosphorus pesticides.
- Bioassays measured DPPH•, ABTS•+, O2•−, and •NO scavenging; AChE, BuChE, and GSK-3β inhibition; and MTT cell viability in hCMEC/D3 and NSC-34 cells. Statistical analysis used one-way ANOVA with Tukey’s test, Pearson correlations, and GraphPad Prism 8.0.1.
Limitations
- The paper does not state a limitations section. Evident from the text: all bioactivity data are in vitro, with no in vivo Alzheimer’s disease models, clinical outcomes, or bioavailability/BBB permeability assessment.
- Evident from the text: only decoctions from commercial samples were tested, so findings may not generalize to other extraction methods, plant sources, or preparations. Cholinesterase inhibition was weak to moderate for most extracts, and GSK-3β inhibition was tested at a single concentration (4.2 μg/mL) rather than as IC50 values.
- Evident from the text: pesticide safety was limited to 21 organochlorine and organophosphorus pesticides in liquid extracts, leaving other contaminant classes and plant materials unassessed.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 56 cited sources checked · 0 supported · 0 flagged
- Findingown data
Chromatographic analysis revealed the presence of several flavonoids, phenolic acids, curcuminoids, phenolic diterpenoids, one alkaloid and one naphthodianthrone in the seven decoctions.
“chromatographic analysis revealed the presence of several flavonoids, phenolic acids, curcuminoids, phenolic diterpenoids, one alkaloid and one naphthodianthrone in the seven decoctions.”
Quote in the paperNot a substantial claim - Findingown data
S. baicalensis decoction showed better DPPH than ABTS radical scavenging activity.
“S. baicalensis decoction showed better DPPH • than ABTS •+ RSA”
Quote in the paperNot a substantial claim - Findingown data
O2•- and •NO scavenging activities were positively correlated (r = 0.600).
“Both O 2 •-and • NO scavenging activities were positively correlated, although with a r far from 1 (r = 0.600)”
Quote in the paperNot a substantial claim - Findingown data
In terms of IC50 values, the most active extracts against DPPH and ABTS radicals were H. perforatum, L. angustifolia, and R. officinalis.
“In terms of IC 50 values, results also demonstrated that the most active extracts against these two radicals were those of H. perforatum, L. angustifolia and R. officinalis.”
Quote in the paperNot a substantial claim - Findingown data
Other phenolic acids and flavonoids previously reported for R. officinalis and L. angustifolia were not found in the current samples.
“Other phenolic acids and flavonoids previously reported for these two species were not found in the current samples (Cesur Turgut et al., 2017;Mena et al., 2016).”
Quote in the paperNot a substantial claim
- Findingown data
At 4.2 μg/mL, all seven extracts displayed more than 60% GSK-3β inhibition.
“On the other hand, at the tested concentration (4.2 μg/mL), all extracts displayed more than 60% of GSK-3β inhibition”
Quote in the paperSubstantial claim - Findingown data
The total phenolic content of the analysed samples varied between 29.00 ± 3.49 mg GAE/g extract dw for T. foenum-graecum and 327.31 ± 26.88 mg GAE/g extract dw for R. officinalis.
“The values of TPC for the analysed samples varied between 29.00 ± 3.49 mg GAE/g extract dw (T.foenum-graecum) and 327.31 ± 26.88 mg GAE/g extract dw (R. officinalis) as displayed in Table 2.”
Quote in the paperNot a substantial claim - Findingown data
All extracts displayed weak to moderate acetylcholinesterase inhibition.
“displayed weak to moderate acetylcholinesterase”
Quote in the paperNot a substantial claim - Findingown data
All extracts were able to scavenge free radicals.
“All extracts were able to scavenge free radicals”
Quote in the paperSubstantial claim - Findingown data
R. officinalis decoction was the only one displaying inhibitory potential over 50% for both cholinesterases.
“Since R. officinalis decoction was the only one displaying inhibitory potential over 50% for both cholinesterases, the type of enzyme inhibition was further studied for this extract (Fig. 4 A and B).”
Quote in the paperSubstantial claim - Findingown data
Ginkgo biloba and Lavandula angustifolia decoctions were the least cytotoxic to hCMEC/D3 and NSC-34 cell lines.
“G. biloba and L. angustifolia decoctions were the less cytotoxic to hCMEC/D3 and NSC-34 cell lines.”
Quote in the paperNot a substantial claim - Findingown data
DPPH and ABTS radical scavenging activities were well correlated (r = 0.867).
“DPPH • and ABTS •+ RSA were well correlated (r = 0.867)”
Quote in the paperNot a substantial claim - Findingown data
L. angustifolia decoction contained two hydroxycinnamic acids (compounds 4 and 8).
“Other two hydroxycinnamic acids (4 and 8) were also identified in L. angustifolia, while protocatechuic acid (3), caffeic acid (9), an apigenin derivative (33), carnosol (38) and carnosic acid (43) were also found in R. officinalis decoction (Table 3).”
Quote in the paperNot a substantial claim - Findingown data
The most active decoctions against O2•- and •NO were R. officinalis (IC50 = 53.65 and 121.33 μg/mL) and H. perforatum (IC50 = 59.34 and 151.25 μg/mL).
“As reported in Table 2, the most active decoctions against O 2 •-and • NO were those prepared with R. officinalis (IC 50 = 53.65 μg/mL and 121.33 μg/mL, respectively) and H. perforatum (IC 50 = 59.34 and 151.25 μg/mL, respectively).”
Quote in the paperSubstantial claim - Findingown data
S. baicalensis was the most potent extract for GSK-3β inhibition (83.42 ± 2.99%).
“being S. baicalensis the most potent extract (83.42 ± 2.99%) (Fig. 3F).”
Quote in the paperNot a substantial claim - Findingown data
No statistical differences were found between R. officinalis and H. perforatum decoctions and those of S. baicalensis and G. biloba for O2•- and •NO scavenging.
“Moreover, no statistical differences were found between both decoctions and those of S. baicalensis and G. biloba (Table 2).”
Quote in the paperNot a substantial claim - Findingown data
All extracts were moderate glycogen synthase kinase-3β inhibitors.
“were moderate glycogen synthase kinase-3β inhibitors”
Quote in the paperSubstantial claim - Findingown data
In the current study, S. baicalensis was not more active than C. longa and G. biloba against ABTS.
“On the other hand, Li et al. (2013) observed that S. baicalensis was more active than C. longa and G. biloba against ABTS •+ , which was not verified in the current study.”
Quote in the paperNot a substantial claim - Findingown data
Among the 7 analysed samples, no organochlorine and organophosphorus pesticides were found.
“The analyses performed in this study demonstrated that among the 7 analysed samples, no presence of organochlorine and organophophorus pesticides was found (Fig. 2).”
Quote in the paperSubstantial claim - Findingown data
DPPH and ABTS radical scavenging activities had poor correlation with total phenolic content (r = 0.410 for DPPH and r = 0.503 for ABTS).
“however, a poor correlation was found between these two activities and TPC (r = 0.410 for DPPH • and r = 0.503 for ABTS •+ ).”
Quote in the paperNot a substantial claim - Findingown data
No statistical differences were found between the extracts for GSK-3β inhibition.
“However, no statistical differences were found between the results.”
Quote in the paperNot a substantial claim - Findingown data
All extracts displayed weak to moderate butyrylcholinesterase inhibition.
“butyrylcholinesterase inhibition”
Quote in the paperNot a substantial claim - Premisecitation
Plant secondary metabolites including alkaloids, flavonoids, and phenolic acids play a key role in improving regeneration and/or inhibiting neurodegeneration.
“The secondary metabolites of plants including alkaloids, flavonoids, and phenolic acids play a key role in improving regeneration and/or inhibiting neurodegeneration (Kamran et al., 2020).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kamran et al., 2020
Not checked in the free run.
- Premisecitation
Alzheimer's disease is a complex and multifactorial disorder.
“a complex and multifactorial disorder, such as AD, must be approached with multitarget-directed ligands (MTDLs) (Agis-Torres et al., 2014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Agis-Torres et al., 2014 source
Not checked in the free run.
- Premisecitation
Clinical trials of Ginkgo biloba extracts on dementia have inconsistent findings due to heterogeneity in dosages, duration, and sample characteristics.
“The effects of G. biloba extracts on dementia have been assessed by several controlled clinical trials, but, the findings are inconsistent due to heterogeneity in the dosages and duration of the interventions, and the sample characteristics across different trials (Yuan et al., 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yuan et al., 2017 source
Not checked in the free run.
- Premisecitation
Hypericum perforatum treatment significantly reduced soluble and aggregated Aβ levels in the brains of transgenic mice.
“Concerning AD, H. perforatum treatment has also shown to significantly reduce soluble and aggregated Aβ levels in the brains of transgenic mice (C57BL/6J-APP/PS±mice) (Brenn et al., 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Brenn et al., 2014 source
Not checked in the free run.
- Premisecitation
There is still a lack of effective drugs for the treatment of Alzheimer's disease.
“Despite incredible efforts, there is still a lack of effective drugs for the treatment of AD.”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Increased GSK-3β activity induces Aβ deposition extracellularly.
“Furthermore, increased GSK-3β activity also induces Aβ deposition extracellularly (Griebel et al., 2019;Toral-Rios et al., 2020).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Ginkgo biloba constituents, standardized extracts and leaf tablets showed protection in different in vivo models of Alzheimer's disease.
“G. biloba constituents, standardized extracts and leaf tablets showed protection in different in vivo models of AD (Su et al., 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Su et al., 2014
Not checked in the free run.
- Premisecitation
Scutellaria baicalensis improved memory in the ibotenic acid-induced memory deficient model.
“Heo et al. (2009) showed that S. baicalensis improved memory in the ibotenic acid-induced memory deficient model and could be possibly a good therapeutic candidate to treat degenerating neuronal diseases accompanied by memory loss.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Heo et al., 2009 source
Not checked in the free run.
- Premisecitation
Fenugreek and its constituents have positive effects in several in vitro and in vivo Alzheimer's disease models.
“Zameer et al. (2018) have recently reviewed the positive effect of fenugreek and its constituents on several in vitro and in vivo AD models.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zameer et al., 2018 source
Not checked in the free run.
- Premisecitation
Trigonella foenum-graecum attenuated aluminum chloride-induced tau pathology, oxidative stress, and inflammation in AlCl3-induced Alzheimer rats.
“Concerning neuroprotection, it was shown to attenuate aluminum chloride-induced tau pathology, oxidative stress, and inflammation in AlCl 3 -induced Alzheimer rats (Prema et al., 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Prema et al., 2017 source
Not checked in the free run.
- Interpretationown data
Looking at the 21 pesticides under study, the 7 decoctions are safe for their possible nutraceutical application.
“We can say that looking at the 21 pesticides under study, the 7 decoctions are safe for their possible nutraceutical application.”
Quote in the paperSubstantial claim- Rests on an assumption: Absence of the 21 screened organochlorine and organophosphorus pesticides in the decoctions implies they are safe for possible nutraceutical application.
- Premisecitation
ChE inhibitors are not able to completely stop the progression of AD.
“However, ChE inhibitors are not able to completely stop the progression of AD, and research should focus on the development of multi-target drugs able to counteract the decreased levels of ACh, protein misfolding and associated Aβ aggregation, hyperphosphorylation of tau protein, and oxidative stress (Butterfield and Boyd-Kimball, 2020;Zagórska and Jaromin, 2020).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Rosmarinus officinalis and Lavandula angustifolia extracts are low to moderate acetylcholinesterase inhibitors.
“Although R. officinalis and L. angustifolia extracts are low to moderate AChE inhibitors (Adsersen et al., 2006;Ferreira et al., 2006)”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
The strong antioxidant activity of R. officinalis is attributed to carnosol, carnosic acid, rosmarinic acid, and caffeic acid.
“The strong antioxidant activity of R. officinalis is attributed to some of its chemical constituents, which include carnosol, carnosic acid, rosmarinic acid, and caffeic acid (Rašković et al., 2014)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rašković et al., 2014 source
Not checked in the free run.
- Interpretationreasoning
S. baicalensis exerts antioxidant activity principally by single-electron transfer instead of hydrogen-atom transfer.
“which may reflect that it exerts antioxidant activity principally by single-electron transfer instead of hydrogen-atom transfer.”
Quote in the paperNot a substantial claim - Premisecitation
The antioxidant activity of Lavandula extracts is mainly due to rosmarinic acid.
“and the antioxidant activity of the Lavandula extracts is mainly due to the presence of rosmarinic acid (Blažeković et al., 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Blažeković et al., 2010 source
Not checked in the free run.
- Premisecitation
Rosmarinus officinalis extract inhibited Aβ fibrillation to some extent.
“R. officinalis extract inhibited Aβ fibrillation to some extent (Lobbens et al., 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lobbens et al., 2017 source
Not checked in the free run.
- May combine two claims. 31
- Classified as probably not a substantial claim. 26
- The quote only partly states this claim. 6
May combine two claims.
Findingown dataFor R. officinalis non-competitive BuChE inhibition, Vmax was 1.62 × 10−5 M/min, Km was 18.98 × 10−2 mM, and Ki was 747.50 μg/mL.
“while for BuChE inhibition values of V max = 1.62 × 10 -5 M/min, K m = 18.98 × 10 -2 mM and K i = 747.50μg/mL were obtained.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataNo pesticides residues were detected.
“No pesticides residues were detected.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFor hCMEC/D3 cells, S. baicalensis (IC50 = 633.52 μg/mL) and H. perforatum (IC50 = 731.87 μg/mL) moderately affected viability, while T. foenum-graecum, R. officinalis, and C. longa induced a marked decrease (IC50 < 250 μg/mL).
“hCMEC/D3 cells viability was moderately affected by S. baicalensis (IC 50 = 633.52μg/mL) and Hypericum perforatum (IC 50 = 731.87μg/mL) while T. foenum graecum, R. officinalis and C. longa induced a marked decreased in cells viability (IC 50 < 250 μg/mL).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataC. longa decoction contained p-coumaric acid, ferulic acid, and three curcuminoids: bisdemethoxycurcumin, demethoxycurcumin, and curcumin.
“Besides p-coumaric (11) and ferulic (13) acids, three curcuminoids were identified in C. longa decoction, namely, bisdemethoxycurcumin (39), demethoxycurcumin (41) and curcumin (42) (Table 3).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFor NSC-34 cells, G. biloba, H. perforatum, C. longa, and L. angustifolia were the least cytotoxic (IC50 > 1000 μg/mL), followed by S. baicalensis (IC50 = 722.11 μg/mL) and R. officinalis (IC50 = 634.66 μg/mL), and T. foenum-graecum was the most toxic (IC50 < 250 μg/mL).
“Concerning NSC-34, G. biloba, H. perforatum, C. longa and L. angustifolia were the less cytotoxic (IC 50 > 1000 μg/mL), followed by S. baicalensis (IC 50 = 722.11μg/mL) and R. officinalis (IC 50 = 634.66μg/mL) and the most toxic one was T. foenum graecum (IC 50 < 250 μg/mL).”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationOnly S. baicalensis, G. biloba, and R. officinalis decoctions achieved 50% AChE inhibition, with IC50 values of 796.55, 2076.07, and 1068.44 μg/mL, respectively.
“Concerning ChEs inhibition, it was only possible to achieve 50% of AChE inhibition for decoctions prepared with S. baicalensis (IC 50 = 796.55μg/mL) (Delerue et al., 2021), G. biloba (IC 50 = 2076.07μg/mL) (Delerue et al., 2021), and R. officinalis (IC 50 = 1068.44μg/mL)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFor R. officinalis non-competitive AChE inhibition, Vmax was 2.22 × 10−5 M/min, Km was 15.28 × 10−2 mM, and Ki was 501.60 μg/mL.
“The parameters V max , K m , and K i were determined with this model and were found to be 2.22 × 10 -5 M/min, 15.28 × 10 -2 mM and 501.60 μg/mL for AChE inhibition, respectively”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataH. perforatum and R. officinalis decoctions were the most potent samples for DPPH and ABTS scavenging, while C. longa was the weakest.
“From all samples, H. perforatum and R. officinalis decoctions were the most potent ones for DPPH • (100.01 ± 7.43 and 91.57± 9.16 mg GAE/g extract dw, respectively) and ABTS •+ (350.45 ± 10.55 and 282.94 ± 12.30 mg TE/g extract dw, respectively) assays, while C. longa was the weakest one (22.54± 3.34 and 30.38 ± 1.96 TE/g extract dw).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataRosmarinic acid was present in both R. officinalis and L. angustifolia decoctions, in higher amount in R. officinalis than in L. angustifolia (21.06 ± 1.97 vs 13.28 ± 1.68 mg/g extract dw).
“Rosmarinic acid (21) was present in both species from Lamiaceae family, in higher amounts in R. officinalis than in L. angustifolia (21.06 ± 1.97 vs 13.28 ± 1.68 mg/g extract dw).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFor R. officinalis decoction, a non-competitive inhibition model fitted the experimental results best for both AChE and BuChE, with highest R2 and lowest sum of squared errors.
“Different models (uncompetitive, competitive, non-competitive) were fitted to the experimental results and, for both enzymes, non-competitive inhibition model resulted in the highest R 2 (0.8530 for AChE and 0.9275 for BuChE) and AdjR 2 (0.8412 for AChE and 0.9214 for BuChE) values and the lowest sum of the squared errors (1.11 × 10 -10 for AChE and 2.15 × 10 -11 for BuChE).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataR. officinalis decoction contained protocatechuic acid, caffeic acid, an apigenin derivative, carnosol, and carnosic acid.
“Other two hydroxycinnamic acids (4 and 8) were also identified in L. angustifolia, while protocatechuic acid (3), caffeic acid (9), an apigenin derivative (33), carnosol (38) and carnosic acid (43) were also found in R. officinalis decoction (Table 3).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataH. perforatum decoction contained small amounts of hypericin (0.18 ± 0.08 mg/g extract dw), with quercetin-3-O-galactoside (27.00 ± 7.74 mg/g extract dw) and quercetin-3-O-glucoside (11.74 ± 1.99 mg/g extract dw) as major constituents, followed by catechin derivatives, quercetin-3-O-rhamnoside, and protocatechuic acid.
“H. perforatum contained small amounts of the naphthodianthrone hypericin (44; 0.18 ± 0.08 mg/g extract dw), and the major constituents were quercetin-3-O-galactoside (22; 27.00 ± 7.74 mg/g extract dw) and quercetin-3-O-glucoside (24; 11.74 ± 1.99 mg/g extract dw), followed by catechin derivatives (7, 10 and 12), quercetin-3-Orhamnoside (27) and protocatechuic acid (3) (Table 3).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOnly L. angustifolia and R. officinalis decoctions displayed considerable BuChE inhibition, with IC50 values of 2145.94 and 858.75 μg/mL, respectively.
“while only L. angustifolia and R. officinalis displayed considerable BuChE inhibition (IC 50 = 2145.94and 858.75 μg/mL, respectively) (Fig. 3A-E).”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataThe HPLC-DAD analysis of the five decoctions other than S. baicalensis and G. biloba showed very distinct chemical compositions.
“The HPLC-DAD analysis of the other five decoctions showed very distinct chemical compositions (Fig. 1, Table 3).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataT. foenum-graecum decoction contained trigonelline as its major compound (16.41 ± 0.24 mg/g extract dw), followed by four C-glycosyl flavones and one apigenin derivative.
“T. foenum-graecum contained an alkaloid, trigonelline (1), as its major compound (16.41 ± 0.24 mg/g extract dw), followed by four C-glycosyl flavones (luteolin-8-C-glucoside (14), apigenin-8-C-glucoside (15), luteolin-6-C-glucoside (17) and apigenin-6-C-glucoside (19)) and one apigenin derivative (26) (Table 3).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataO2•- and •NO scavenging activities were negatively correlated with total phenolic content (r = -0.813 and r = -0.631, respectively).
“and were negatively correlated with TPC (r = -0.813and r = -0.631,respectively).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataExcept G. biloba and L. angustifolia, which were not cytotoxic at the tested concentrations, all other samples induced a concentration-dependent decrease in cell viability in both hCMEC/D3 and NSC-34 cell lines.
“Except for G. biloba (IC 50 > 1000 μg/mL) and L. angustifolia (IC 50 > 1000 μg/mL), which were not cytotoxic at the tested concentrations, all the other samples induced a concentration-dependent decrease in cell viability in both cell lines.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGinkgo biloba leaf extract has become one of the most widely used herbal remedies for dementia.
“The extract from G. biloba leaves has become one of the most widely used herbal remedies for dementia (Yuan et al., 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yuan et al., 2017 source
Not checked in the free run.
May combine two claims.
PremisecitationMixtures of drugs or plant extracts might have advantages over single drugs by impacting different targets simultaneously, potentially being a more effective treatment option for Alzheimer's disease.
“Mixtures of drugs or plant extracts might have advantages over single drugs as they can impact different targets simultaneously, which could be a novel and more effective treatment option for AD (Chen et al., 2021).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Chen et al., 2021 source
Not checked in the free run.
May combine two claims.
PremisecitationThere are five drugs in clinic for Alzheimer's disease, including three cholinesterase inhibitors, that only provide palliative and supporting treatment.
“There are five drugs in clinic, including three cholinesterase inhibitors, that only provide palliative and supporting treatment (Butterfield and Boyd-Kimball, 2020;Zagórska and Jaromin, 2020;Gul et al., 2021).”
Quote in the paperSubstantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationBACE-1 and GSK-3β inhibition are being studied as possible targets for Alzheimer's disease.
“Nowadays, other possible targets are being studied, such as beta-secretase 1 (BACE-1) and glycogen synthase kinase-3β (GSK-3β) inhibition (De Simone et al., 2021;Prati et al., 2015).”
Quote in the paperNot a substantial claim0 of 2 sources checkedClassified as probably not a substantial claim. May combine two claims.
PremisecitationReactive oxygen species and reactive nitrogen species can damage macromolecules and compromise normal cell functions.
“ROS and reactive nitrogen species (RNS) are capable of damaging and modifying several types of macromolecules, such as DNA, RNA, lipids, and proteins, compromising the normal functions of the cells (Butterfield and Boyd-Kimball, 2020; Persson et al., 2014).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Butterfield and Boyd-Kimball, 2020 source
Not checked in the free run.
- cites Persson et al., 2014
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSeveral natural products, mainly plant extracts, have been reported to be used in traditional medicine for neuroprotective, memory enhancing, and antiageing functions.
“Several natural products, mainly plants extracts, have been reported to be used in traditional medicine for neuroprotective, memory enhancing, and antiageing functions”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). The quote only partly states this claim.
Study design and conductown dataThe extracts were analysed in triplicate (n = 3) by HPLC-DAD.
“The extracts were analysed (n = 3) on an analytical HPLC unit”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenStatistical analysis used one-way ANOVA followed by Tukey's test with p values less than 0.05 considered statistically significant.
“Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by the Tuckey's test and p values less than 0.05 were considered to be statistically significant.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims. The quote only partly states this claim.
Study design and conductown dataGSK-3β inhibition assays were tested in duplicate and the experiments repeated three times.
“All decoctions were tested in duplicate, and the experiments were repeated three times.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThis study demonstrated the importance of plant extracts as multitarget agents, showing benefits of seven medicinal plants against different Alzheimer's hallmarks, including oxidative and nitrosative stresses and cholinesterases and GSK-3β inhibition.
“This study demonstrated the importance of plant extracts as multitarget agents, showing the benefits of seven different medicinal plants against different Alzheimer's hallmarks, including oxidative and nitrosative stresses and cholinesterases and GSK-3β inhibition.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationWHO guidelines for assessing quality of herbal medicines describe potentially hazardous contaminants and residues and report national and regional limits.
“The WHO guidelides for assessing quality of herbal medicines describes the potentially hazardous contaminants and residues that may occur in herbal medicines and reports the national and regional limits set for the various types contaminants (World Health Organization, 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites World Health Organization, 2007
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe purity of plants may be compromised by dirt, weeds, bacteria, moulds, and multiple contaminants such as pesticides, toxic metals, and polychlorinated biphenyls.
“The purity of the plants may be compromised due to several factors, namely, by the presence of dirt, weeds, bacteria, moulds, and multiple contaminants (e.g., pesticides, toxic metals, polychlorinated biphenyls (PCB), etc) (Jordan et al., 2010;Luo et al., 2021).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe total phenolic content experiment was performed in triplicate (n = 3).
“The experiment was performed in triplicate (n = 3).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims. The quote only partly states this claim.
Study design and conductnone givenNSC-34 cells at passages 4-6 were used with n = 5.
“Passages 4-6 were used (n = 5).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenPearson correlation analyses were carried out to determine possible relations between the contents of phenolic compounds and the observed bioactivities.
“Pearson correlation analyses were carried out to determine the possible relations between the contents of phenolic compounds and the observed bioactivities.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe quality of herbal medicine products is a particular challenge in safety data.
“A particular challenge in safety data on herbal medicines is the quality of the products.”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenFor all radical scavenging assays, triplicate measurements were made for each extract.
“For all the assays, triplicate measurements were made for each extract.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationDecoctions from Ginkgo biloba leaves and Scutellaria baicalensis roots displayed moderate acetylcholinesterase and butyrylcholinesterase inhibition and strong scavenging activity against hydrogen peroxide.
“Therefore, in a previous study, we have demonstrated that the decoctions prepared from the leaves of G. biloba and from the roots of S. baicalensis displayed moderate acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibition as well as a strong scavenging activity against hydrogen peroxide, a ROS (Delerue et al., 2021).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Delerue et al., 2021 source
Not checked in the free run.
May combine two claims.
Interpretationown dataThe decoctions from S. baicalensis, G. biloba, L. angustifolia, and R. officinalis are moderate to weak cholinesterase inhibitors, while C. longa and T. foenum-graecum decoctions are not active against these enzymes.
“These results demonstrated that the decoctions prepared from these four species are moderate to weak cholinesterases inhibitors, while those prepared from C. longa and T. foenum graecum (Fig. 3B and D) are not active against these enzymes.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll experiments were repeated at least three times.
“All the experiments were repeated at least three times.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims. The quote only partly states this claim.
Study design and conductnone givenhCMEC/D3 cells at passages 50-54 were employed with n = 5.
“Passages 50-54 were employed (n = 5).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationRosmarinus officinalis and Lavandula angustifolia contain rosmarinic acid, which is active against amyloid fibrillation.
“Both species contain rosmarinic acid that is active against amyloid fibrillation (Adsersen et al., 2006;Lobbens et al., 2017).”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing), S4 (based). May combine two claims. The quote only partly states this claim.
Study design and conductnone givenAcetylcholinesterase and butyrylcholinesterase inhibition assays were tested in triplicate and the experiments repeated three times.
“Results are expressed as IC 50 values and decoctions were tested in triplicate and the experiments repeated three times.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable).
Interpretationown dataThe results extend the knowledge on the potential use of plant extracts to combat multifactorial disorders, giving new insights into therapeutic avenues for Alzheimer's disease.
“The results extend the knowledge on the potential use of plant extracts to combat multifactorial disorders, giving new insights into therapeutic avenues for Alzheimer's disease.”
Quote in the paperNot a substantial claim- Rests on an assumption: The in vitro bioassays used (radical scavenging, enzyme inhibition, cell viability) are predictive of neuroprotective effects in Alzheimer's disease.
May combine two claims.
InterpretationreasoningTaking all results together, T. foenum-graecum and C. longa were the weakest antioxidant samples, while R. officinalis and H. perforatum are among the most active, showing potential to counteract ROS and RNS.
“Taking all the results together, T. foenum graecum and C. longa were the weakest antioxidant samples, while R. officinalis and H. perforatum are among the most active ones, showing their potential to counteract ROS and RNS.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe antioxidant activity of H. perforatum can be attributed to flavonoids and phenolic acids, while phloroglucinols and naphthodianthrones have no significant activity.
“According to Orčić et al. (2011), the antioxidant activity of H. perforatum can be attributed to flavonoids and phenolic acids, while phloroglucinols and naphthodianthrones have no significant activity.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Orčić et al. (2011)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe presence of organochlorine and organophosphorus pesticides in medicinal plants is commonly reported in the literature.
“Although the presence of organochlorine and organophosphorus pesticides in medicinal plants is commonly reported in the literature (Fu et al., 2019;Luo et al., 2021;Xu et al., 2011), in this work it has not been verified.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Fu et al., 2019
Not checked in the free run.
- cites Luo et al., 2021 source
Not checked in the free run.
- cites Xu et al., 2011
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTrigonelline is an important chemotaxonomic marker of Trigonella species.
“Trigonelline is an important chemotaxonomic marker of Trigonella species (Mohammadi et al., 2020;Shailajan et al., 2011;Zameer et al., 2018) and was found to be the major compound in the sample analysed herein.”
Quote in the paperNot a substantial claim0 of 3 sources checkedClassified as probably not a substantial claim.
PremisecitationAn imbalance between protective •NO and highly cytotoxic ONOO− may be crucial in the initial step of development of several vascular and neuronal diseases, including AD.
“An imbalance between protective • NO and highly cytotoxic ONOO -may be crucial in the initial step of the development of several vascular and neuronal diseases, including AD (Malinski, 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Malinski, 2007 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRosmarinic acid is the most important chemotaxonomic marker of species from the Lamiaceae family.
“Concerning R. officinalis and L. angustifolia, it is also worth to mention that rosmarinic acid is also the most important chemotaxonomic marker of species from Lamiaceae family (Janicsák et al., 1999)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Janicsák et al., 1999 source
Not checked in the free run.
May combine two claims.
PremisecitationLeaf maturation (green vs yellow) and plant sex (male vs female) influence the amount of phenolics in G. biloba, being responsible for the wide range of TPC values reported in literature.
“Indeed, for G. biloba, it was found that leaf maturation (green vs yellow) and plant sex (male vs female) have influence on the amount of phenolics, being these factors responsible for the wide range of TPC values reported in literature (Kobus-Cisowska et al., 2020;Koczka et al., 2015).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFor R. officinalis, the phenolic diterpenes carnosic acid and carnosol are considered important chemotaxonomic markers.
“and, for R. officinalis, the phenolic diterpenes carnosic acid and carnosol are also considered important (Mena et al., 2016;Troncoso et al., 2005;Yeddes et al., 2019;Yilmaz et al., 2018;Zhang et al., 2012).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIt is difficult to guarantee total safety of herbal medicines as it involves different areas, such as environmental and agricultural practices.
“However, it is a difficult task to guarantee total safety as it involves different areas, such as environmental and agricultural practices (World Health Organization, 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites World Health Organization, 2007
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSome pesticides showed a significant decrease in transfer rate from plant to infusion.
“Recently, Florea et al. (2020) reported the degree of pesticides transfer in three types of preparations (infusion, decoction and maceration), and demonstrated that some pesticides showed a significant decrease in transfer rate from plant to infusion.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Florea et al. (2020) source
Not checked in the free run.
The paper relies on this without support.
The in vitro bioassays used (radical scavenging, enzyme inhibition, cell viability) are predictive of neuroprotective effects in Alzheimer's disease.
“The results extend the knowledge on the potential use of plant extracts to combat multifactorial disorders, giving new insights into therapeutic avenues for Alzheimer's disease.”
The paper relies on this without support.
This is the first study on GSK-3β inhibition of these plant species.
“To the best of our knowledge, this is the first study on the GSK-3β inhibition of these plant species.”
The paper relies on this without support.
The cholinergic hypothesis holds that the main cause of AD is the reduction in acetylcholine synthesis.
“According to the cholinergic hypothesis, the main cause of AD is the reduction in acetylcholine synthesis.”
The paper relies on this without support.
hCMEC/D3 is a stable, easily grown blood brain barrier model cell line.
“hCMEC/D3 represents a stable, easily grown blood brain barrier (BBB) model cell line and NSC-34 is a hybrid cell line produced by fusion of neuroblastoma with mouse motoneuron-enriched primary spinal cord cells.”
The paper relies on this without support.
There are no previous studies about the effect of these decoctions on the viability of hCMEC/D3 and NSC-34 cell lines.
“To the best of our knowledge, there are no previous studies about the effect of these decoctions on the viability of these cell lines.”
The paper relies on this without support.
Absence of the 21 screened organochlorine and organophosphorus pesticides in the decoctions implies they are safe for possible nutraceutical application.
“We can say that looking at the 21 pesticides under study, the 7 decoctions are safe for their possible nutraceutical application.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Alkaloids, flavonoids, and phenolic acids are among the essential secondary metabolites of plants that play a significant role in preventing neurodegeneration in Alzheimer's disease.
“Alkaloids, flavonoids, and phenolic acids are among the essential secondary metabolites of plants that play a significant role in preventing neurodegeneration in AD [17,58,59].”
From Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights (2023) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
DPPH activity uses conflicting equivalent units
MinorThe methods say DPPH activity was expressed in Trolox equivalents (mg TE/g dw), but the results report the DPPH values in gallic acid equivalents (mg GAE/g extract dw).
“For DPPH • -RSA assay, a calibration curve was prepared with Trolox, and the antioxidant activity was expressed as mg of Trolox equivalents per g of dw of extract (mg TE/g dw)”
“DPPH • (100.01 ± 7.43 and 91.57± 9.16 mg GAE/g extract dw, respectively)”
Cites
Ferreira, A., Proença, C., Serralheiro, M. L. M., & Araújo, M. E. M. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.04.010 · Cited by 480 · see citing works
Zhao, T.-T., Tang, H., Xie, L., et al. (2019) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13129 · Cited by 478 · see citing works
WHO guidelines for assessing quality of herbal medicines with reference to contaminants and residues
Solimene, U., Alkofahi, A., Allemann, C., Amigoni, M., Aspan, R., Azimova, S. S., Bloodworth, B. C., Caccialanza, G., Caizzi, A., Cheraghali, A. M., et al. (2007) · Cited by 476 · see citing works
Rašković, A., Milanović, I., Pavlović, N., Ćebović, T., Vukmirović, S., & Mikov, M. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-225 · Cited by 470 · see citing works
Zhang, L., Ravipati, A. S., Koyyalamudi, S. R., Jeong, S., Reddy, N., Smith, P. T., Bartlett, J. R., Shanmugam, K., Münch, G. W., & Wu, M. J. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf203146e · Cited by 426 · see citing works
Jordan, S. A., Cunningham, D. G., & Marles, R. J. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.12.005 · Cited by 415 · see citing works
Oxidative Stress in Alzheimer’s Disease: Why Did Antioxidant Therapy Fail?
Persson, T., Popescu, B. O., & Cedazo-Mı́nguez, Á. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/427318 · Cited by 318 · see citing works
Mena, P., Cirlini, M., Tassotti, M., Herrlinger, K., Dall’Asta, C., & Del Rio, D. (2016) · Molecules · doi:10.3390/molecules21111576 · Cited by 288 · see citing works
Early-Life Risk Factors for Alzheimer Disease
Borenstein, A. R., Copenhaver, C. I., & Mortimer, J. A. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000201854.62116.d7 · Cited by 259 · see citing works
Neuroprotective Natural Products for Alzheimer’s Disease
Chen, X., Drew, J., Berney, W., & Lei, W. (2021) · Cells · doi:10.3390/cells10061309 · Cited by 236 · see citing works
Huang, W., Lee, A., & Yang, C.-H. (2006) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.50698 · Cited by 230 · see citing works
Zhang, Y., Smuts, J. P., Dodbiba, E., Rangarajan, R., Lang, J. C., & Armstrong, D. W. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf302179c · Cited by 222 · see citing works
Nitric oxide and nitroxidative stress in Alzheimer's disease
Malinski, T. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11208 · Cited by 220 · see citing works
Antioxidant capacities and total phenolic contents of infusions from 223 medicinal plants
Li, S., Li, S.-K., Gan, R., Song, F.-L., Kuang, L., & Li, H. (2013) · Industrial Crops and Products · doi:10.1016/j.indcrop.2013.09.017 · Cited by 212 · see citing works
Adsersen, A., Gauguin, B., Gudiksen, L., & Jäger, A. K. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.09.032 · Cited by 205 · see citing works
Agis-Torres, A., Sollhuber, M., Fernandez, M., & Sanchez-Montero, J. M. (2014) · Current Neuropharmacology · doi:10.2174/1570159x113116660047 · Cited by 202 · see citing works
Rethinking Ginkgo biloba L.: Medicinal uses and conservation
Isah, T. (2015) · Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review · doi:10.4103/0973-7847.162137 · Cited by 160 · see citing works
GSK3β and tau protein in Alzheimer's disease and epilepsy
Toral-Rios, D., Pichardo-Rojas, P. S., Alonso-Vanegas, M., & Campos-Peña, V. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00019 · Cited by 158 · see citing works
Effects of Ginkgo biloba on dementia: an overview of systematic reviews
Yuan, Q., Wang, C.-W., Shi, J., & Lin, Z.-X. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.12.005 · Cited by 148 · see citing works
Neuroprotective and Cognitive Enhancement Potentials of Baicalin: A Review
Sowndhararajan, K., Deepa, P., Kim, M.-J., et al. (2018) · Brain Sciences · doi:10.3390/brainsci8060104 · Cited by 146 · see citing works
Comparative studies of the rosmarinic and caffeic acid contents of Lamiaceae species
Janicsák, G., Máthé, I., Miklóssy-Vári, V., & Blunden, G. (1999) · Biochemical Systematics and Ecology · doi:10.1016/s0305-1978(99)00007-1 · Cited by 133 · see citing works
Multitarget drug discovery for Alzheimer's disease: triazinones as BACE-1 and GSK-3β inhibitors
Prati, F., De Simone, A., Bisignano, P., Armirotti, A., Summa, M., Pizzirani, D., Scarpelli, R., Perez, D. I., Andrisano, V., Perez‐Castillo, A., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201410456 · Cited by 128 · see citing works
Self-citationSpiridon, I., Colceru-Mihul, S., Anghel, N., Teacă, C. A., Bodîrlău, R., & Armatu, A. (2011) · Natural Product Research · doi:10.1080/14786419.2010.521502 · Cited by 127 · see citing works
A High Throughput Luminescent Assay for Glycogen Synthase Kinase-3 β Inhibitors
Baki, A., Bielik, A., Molnár, L. M., Szendrei, G. I., & Keserű, G. M. (2007) · Assay and Drug Development Technologies · doi:10.1089/adt.2006.029 · Cited by 126 · see citing works
Antioxidant activity relationship of phenolic compounds in Hypericum perforatumL.
Orčić, D., Mimica–Dukić, N., Francišković, M., et al. (2011) · Chemistry Central Journal · doi:10.1186/1752-153x-5-34 · Cited by 125 · see citing works
Martino, R. M. C. D., Simone, A. D., Andrisano, V., Bisignano, P., Bisi, A., Gobbi, S., Rampa, A., Fato, R., Bergamini, C., Pérez, D. I., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00894 · Cited by 124 · see citing works
Self-citationRaclariu-Manolică, A. C., Păltinean, R., Vlase, L., Labarre, A., Manzanilla, V., Ichim, M. C., Crișan, G., Brysting, A. K., & de Boer, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-01389-w · Cited by 117 · see citing works
Johnson, J. L., Rupasinghe, S. G., Stefani, F., et al. (2011) · Journal of Medicinal Food · doi:10.1089/jmf.2010.0310 · Cited by 116 · see citing works
Gu, X., Xu, L.-J., Liu, Z., Wei, B., Yang, Y., Xu, G., Yin, X., & Wang, W. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.05.052 · Cited by 113 · see citing works
De Simone, A., Tumiatti, V., Andrisano, V., & Milelli, A. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00931 · Cited by 110 · see citing works
Self-citationFernandes, V. C., de Freitas, M. A. R., Pacheco, J. G., et al. (2018) · Journal of Chromatography A · doi:10.1016/j.chroma.2018.06.045 · Cited by 109 · see citing works
Self-citationDifferentiated NSC-34 motoneuron-like cells as experimental model for cholinergic neurodegeneration
Maier, O., Böhm, J., Dahm, M., Brück, S., Beyer, C., & Johann, S. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.03.008 · Cited by 108 · see citing works
Satheeshkumar, N., Mukherjee, P. K., Bhadra, S., & Saha, B. P. (2009) · Phytomedicine · doi:10.1016/j.phymed.2009.06.006 · Cited by 107 · see citing works
Cvetanović, A. D., Švarc‐Gajić, J., Zeković, Z. P., Jerković, J., Zengin, G., Gašić, U. M., Tešić, Ž., Mašković, P., Soares, C. M. D., Barroso, M. F., et al. (2018) · Food Chemistry · doi:10.1016/j.foodchem.2018.07.154 · Cited by 99 · see citing works
Self-citationGriebel, G., Stemmelin, J., Lopez-Grancha, M., Boulay, D., Boquet, G., Slowinski, F., Pichat, P., Beeské, S., Tanaka, S., Mori, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-54557-5 · Cited by 97 · see citing works
Pinto, D., Cádiz‐Gurrea, M. D. L. L., Sut, S., Ferreira, A. S., Leyva‐Jiménez, F. J., Dall’Acqua, S., Segura‐Carretero, A., Delerue-Matos, C. M., & Rodrigues, F. (2020) · Journal of CO2 Utilization · doi:10.1016/j.jcou.2020.101194 · Cited by 96 · see citing works
Self-citationBlažeković, B., Vladimir-Knežević, S., Brantner, A., & Štefan, M. B. (2010) · Molecules · doi:10.3390/molecules15095971 · Cited by 95 · see citing works
Flavone C-Glycosides from Seeds of Fenugreek, Trigonella foenum-graecum L.
Rayyan, S., Fossen, T., & Andersen, Ø. M. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf100848c · Cited by 94 · see citing works
Neurodegeneration in Alzheimer's disease: caspases and synaptic element interdependence
Bredesen, D. E. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-27 · Cited by 94 · see citing works
Prema, A., Justin Thenmozhi, A., Manivasagam, T., Mohamed Essa, M., & Guillemin, G. J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161103 · Cited by 90 · see citing works
Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease
Butterfield, D. A., & Boyd-Kimball, D. (2020) · Antioxidants · doi:10.3390/antiox9090818 · Cited by 85 · see citing works
Luo, L., Dong, L., Huang, Q., Ma, S., Fantke, P., Li, J., Jiang, J., Fitzgerald, M., Yang, J., Jia, Z., et al. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2020.127477 · Cited by 81 · see citing works
Altun, M. L., Yılmaz, B. S., Orhan, İ. E., et al. (2012) · Industrial Crops and Products · doi:10.1016/j.indcrop.2012.07.017 · Cited by 80 · see citing works
Brenn, A., Grube, M., Jedlitschky, G., Fischer, A., Strohmeier, B., Eiden, M., Keller, M., Groschup, M. H., & Vogelgesang, S. (2014) · Brain Pathology · doi:10.1111/bpa.12069 · Cited by 79 · see citing works
Öztürk, N., Tunçel, M., & Potoğlu-Erkara, İ. (2009) · Pharmaceutical Biology · doi:10.1080/13880200802437073 · Cited by 76 · see citing works
Kalaycıoğlu, Z., Gazioğlu, I., & Erim, F. B. (2017) · Natural Product Research · doi:10.1080/14786419.2017.1299727 · Cited by 75 · see citing works
Troncoso, N., Sierra, H., Carvajal, L., Delpiano, P., & Günther, G. (2005) · Journal of Chromatography A · doi:10.1016/j.chroma.2005.09.008 · Cited by 74 · see citing works
Zameer, S., Najmi, A. K., Vohora, D., & Akhtar, M. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1327200 · Cited by 74 · see citing works
Barroso, M. F., Ramalhosa, M. J., Alves, R. C., Dias, A., Soares, C. M. D., Oliva-Teles, M. T., & Delerue-Matos, C. M. (2016) · Food Control · doi:10.1016/j.foodcont.2016.03.029 · Cited by 67 · see citing works
Self-citationMemory improvement in ibotenic acid induced model rats by extracts of Scutellaria baicalensis
Heo, H., Shin, Y., Cho, W., Choi, Y., Kim, H., & Kwon, Y. K. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.11.026 · Cited by 66 · see citing works
Chen, B., & Chang, H. B. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s87225 · Cited by 64 · see citing works
Determination of curcuminoid colouring principles in commercial foods by HPLC
Lee, J. H., & Choung, M. (2010) · Food Chemistry · doi:10.1016/j.foodchem.2010.07.049 · Cited by 64 · see citing works
Su, Y., Wang, Q., Wang, C., Chan, K., Sun, Y., & Kuang, H. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.12.053 · Cited by 63 · see citing works
Xu, R., Wu, J., Liu, Y., et al. (2011) · Chemosphere · doi:10.1016/j.chemosphere.2011.06.013 · Cited by 61 · see citing works
Effect of Indian Hypericum perforatum Linn on animal models of cognitive dysfunction
Kumar, V., Singh, P. N., Muruganandam, A. V., et al. (2000) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(00)00216-6 · Cited by 60 · see citing works
Akinola, A., Ahmad, S., & Maziah, M. (2014) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.4314/ajtcam.v11i3.2 · Cited by 54 · see citing works
Long, Y., Zhang, W., Wang, F., & Chen, Z. (2014) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2013.10.002 · Cited by 53 · see citing works
Comparison of antioxidant activities between salvianolic acid B and Ginkgo biloba extract (EGb 761)
Liu, C.-S., CHENG, Y., Hu, J., Zhang, W., Chen, N., & Zhang, J. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00378.x · Cited by 52 · see citing works
Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy
Zagórska, A., & Jaromin, A. (2020) · Molecules · doi:10.3390/molecules25153337 · Cited by 51 · see citing works
Yeddes, W., Chalghoum, A., Aidi-Wannes, W., Ksouri, R., & Saidani Tounsi, M. (2019) · Journal of Essential Oil Research · doi:10.1080/10412905.2019.1577305 · Cited by 49 · see citing works
Turgut, A. C., Emen, F. M., Canbay, H. S., et al. (2016) · Journal of the Turkish Chemical Society Section A Chemistry · doi:10.18596/jotcsa.287329 · Cited by 47 · see citing works
Fu, Y., Dou, X., Zhang, L., et al. (2019) · Journal of Chromatography B · doi:10.1016/j.jchromb.2019.121730 · Cited by 46 · see citing works
Mohammadi, M., Mashayekh, T., Rashidi‐Monfared, S., Ebrahimi, A., & Abedini, D. (2020) · Phytochemical Analysis · doi:10.1002/pca.2887 · Cited by 46 · see citing works
Soares, C. M. D., Paíga, P., Marques, M., Neto, T., CARVALHO, A. P. F. D., Paiva, A., Simões, P. C., Costa, L., Bernardo, A., Fernández, N., et al. (2021) · Processes · doi:10.3390/pr9050893 · Cited by 43 · see citing works
Self-citationSilva, A. M., Lago, J. P., Pinto, D., et al. (2021) · Applied Sciences · doi:10.3390/app11114744 · Cited by 43 · see citing works
Self-citationLobato, A., Fernandes, V. C., Pacheco, J. G., et al. (2020) · Journal of Chromatography A · doi:10.1016/j.chroma.2020.461797 · Cited by 38 · see citing works
Self-citationGürbüz, P., Martı́nez, A., Pérez, C., Martínez‐González, L., Göğer, F., & AYRAN, İ. (2019) · Industrial Crops and Products · doi:10.1016/j.indcrop.2019.05.080 · Cited by 37 · see citing works
Paudel, P., Seong, S. H., Zhou, Y., Park, C. H., Yokozawa, T., Jung, H., & Choi, J. S. (2018) · Molecules · doi:10.3390/molecules23112919 · Cited by 34 · see citing works
Liau, P. R., Wu, M. S., & Lee, C. K. (2019) · Molecules · doi:10.3390/molecules24112143 · Cited by 34 · see citing works
Hawrył, A. M., Hawrył, M. A., & Waksmundzka‐Hajnos, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218974 · Cited by 34 · see citing works
Shailajan, S., Sayed, N., Menon, S., Singh, A., & Mhatre, M. (2011) · Pharmaceutical Methods · doi:10.4103/2229-4708.90354 · Cited by 33 · see citing works
Gul, R., Jan, H., Lalay, G., Andleeb, A., Usman, H., Zainab, R., Qamar, Z., Hano, C., & Abbasi, B. H. (2021) · Coatings · doi:10.3390/coatings11060717 · Cited by 33 · see citing works
In vitro model for predicting the access and distribution of drugs in the brain using hCMEC/D3 cells
Sánchez-Dengra, B., González‐Álvarez, I., Sousa, F., Bermejo, M., González‐Álvarez, M., & Sarmento, B. F. C. C. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.04.002 · Cited by 30 · see citing works
Taxonomic Distribution of Medicinal Plants for Alzheimer’s Disease: A Cue to Novel Drugs
Kamran, M. Z., Kousar, R., Ullah, S., Khan, S., Umer, M. F., Rashid, H. U., Khan, Z., Khan, M. I., & Rehman, M. U. (2020) · International Journal of Alzheimer s Disease · doi:10.1155/2020/7603015 · Cited by 26 · see citing works
Aylanç, V., Eskin, B., Zengin, G., Dursun, M., & Çakmak, Y. S. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13463 · Cited by 25 · see citing works
Delerue, T., Fátima Barroso, M., Dias-Teixeira, M., Figueiredo-González, M., Delerue-Matos, C., & Grosso, C. (2021) · Food Research International · doi:10.1016/j.foodres.2020.109857 · Cited by 24 · see citing works
Self-citationLobbens, E. S. B., Vissing, K. J., Jorgensen, L., van de Weert, M., & Jäger, A. K. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.02.020 · Cited by 20 · see citing works
Differences in antioxidant properties of ginkgo leaves collected from male and female trees
Koczka, N., Móczár, Z., Stefanovits-Bányai, É., & Ombódi, A. (2015) · Acta Pharmaceutica · doi:10.1515/acph-2015-0001 · Cited by 19 · see citing works
Megateli, S., & Krea, M. (2018) · Physiology and Molecular Biology of Plants · doi:10.1007/s12298-018-0585-5 · Cited by 18 · see citing works
Flavones with inhibitory effects on glycogen synthase kinase 3β
Jung, Y., Shin, S. Y., Lee, Y. H., et al. (2017) · Applied Biological Chemistry · doi:10.1007/s13765-017-0271-2 · Cited by 17 · see citing works
Kobus-Cisowska, J., Dziedziński, M., Szczepaniak, O., Kusek, W., Kmiecik, D., Ligaj, M., Telichowska, A., Byczkiewicz, S., Szulc, P., & Szwajgier, D. (2020) · CyTA - Journal of Food · doi:10.1080/19476337.2020.1804462 · Cited by 11 · see citing works
Sharma, Y., Fagan, J., & Schaefer, J. (2020) · Journal of Biologically Active Products from Nature · doi:10.1080/22311866.2020.1729239 · Cited by 8 · see citing works
Yilmaz, Ü. T., Çalık, E., Akdulum, B., et al. (2017) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2017.04.004 · Cited by 7 · see citing works
Doležal, R., Houdková, I., Kalász, H., Andrýs, R., Novák, M., Maltsevskaya, N. V., Karásková, N., Kolář, K., Novotná, E., Kuča, K., et al. (2019) · Analytical Letters · doi:10.1080/00032719.2019.1571076 · Cited by 7 · see citing works
In vitro antioxidant properties of herb decoction extracts derived from Epirus, Greece
Skaperda, Z., Kyriazis, I. D., Vardakas, P., et al. (2021) · International Journal of Functional Nutrition · doi:10.3892/ijfn.2021.21 · Cited by 6 · see citing works
Transfer rate of pesticide residues from medicinal plants in different types of extractive solutions
Florea, A. M., Drumea, V., Nita, R. A., Bicu, A., Olariu, L., Dutu, L. E., & Gird, C. E. (2020) · Toxicological & Environmental Chemistry · doi:10.1080/02772248.2020.1773466 · Cited by 4 · see citing works
Détár, E., Németh, É., & Pluhár, Z. (2020) · International Journal of Horticultural Science · doi:10.31421/ijhs/26/2020/5748 · Cited by 4 · see citing works
Flagged first, then by citations
1 of the 88 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Franco, G. A., Interdonato, L., Cordaro, M., Cuzzocrea, S., & Paola, R. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087318 · Cited by 100 · see citing works
Astragaloside IV: A promising natural neuroprotective agent for neurological disorders
Yao, M., Zhang, L., & Wang, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114229 · Cited by 89 · see citing works
Application of Rosmarinic Acid with Its Derivatives in the Treatment of Microbial Pathogens
Kernou, O., Azzouz, Z., Madani, K., & Rijo, P. M. (2023) · Molecules · doi:10.3390/molecules28104243 · Cited by 83 · see citing works
The neuroprotective effect of traditional Chinese medicinal plants—A critical review
Moreira, J. B., Machado, M., Dias-Teixeira, M., Ferraz, R., Delerue-Matos, C. M., & Grosso, C. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.06.009 · Cited by 79 · see citing works
Self-citationNagori, K., Nakhate, K. T., Yadav, K., Ajazuddin, & Pradhan, M. (2023) · Future Pharmacology · doi:10.3390/futurepharmacol3040053 · Cited by 61 · see citing works
Systems pharmacology approaches in herbal medicine research: a brief review
Lee, M., Shin, H., Park, M., Kim, A., Cha, S., & Lee, H. (2022) · BMB Reports · doi:10.5483/bmbrep.2022.55.9.102 · Cited by 60 · see citing works
“as cancer and nervous system disease (3, 4).”
BackgroundGenus Curcuma: chemical and ethnopharmacological role in aging process
Elhawary, E. A., Moussa, A. Y., & Singab, A. N. B. (2024) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04317-w · Cited by 29 · see citing works
Kola, A., Vigni, G., Lamponi, S., & Valensin, D. (2024) · Antioxidants · doi:10.3390/antiox13111419 · Cited by 25 · see citing works
Cacabelos, R., Martínez-Iglesias, O. A., Cacabelos, N., Carrera, I., Corzo, L., & Naidoo, V. (2024) · Life · doi:10.3390/life14121555 · Cited by 31 · see citing works
GASHIMOVA, U. F. (2024) · Advances in Biology & Earth Sciences · doi:10.62476/abes9216 · Cited by 23 · see citing works
Malik, N., Amber, S., & Zahid, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.943163 · Cited by 22 · see citing works
“Plant-originated natural compounds having pharmacological properties have appeared as a promising treatment alternative for AD in recent years (Uddin et al., 2020; Akter et al., 2021; Fernandes et al., 2022).”
BackgroundCheung, S., Zhong, Y., Wu, L., Jia, X., He, M., Ai, Y., Jiao, Q., & Liang, Q. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117976 · Cited by 22 · see citing works
Hafeez, J., Naeem, M., Ali, T., et al. (2023) · Journal of Chemistry · doi:10.1155/2023/3469727 · Cited by 13 · see citing works
Sharma, P. A., Kumari, P., Sharma, M., Sharma, R., Paliwal, A., Srivastava, S., Ashique, S., Bhowmick, M., Adnan, M., & Mir, R. H. (2024) · Journal of Microencapsulation · doi:10.1080/02652048.2024.2373715 · Cited by 11 · see citing works
Cao, Y., Zhang, Y., Jia, Z., Jia, H., Sun, Y., Yuan, H., Bian, Y., Xu, B., Fu, J., & Qin, F. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114077 · Cited by 11 · see citing works
Guo, C., Valdés, A., Sánchez-Martínez, J. D., Ibáñez, E., Bi, J., & Cifuentes, A. (2022) · Foods · doi:10.3390/foods11162464 · Cited by 10 · see citing works
Tamarillo (Solanum betaceum Cav.) wastes and by-products: Bioactive composition and health benefits
Machado, A. M. R., Teodoro, A. J., Mariutti, L. R. B., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37600 · Cited by 9 · see citing works
“Intracellular accumulations of neurotoxic A β oligomers; the intracellular hyperphosphorylated tau protein leading to the formation of neurofibrillary tangles (NFTs); and neuronal loss in key brain regions involved in memory and cognition [75].”
BackgroundFlavonoids as Markers in Herbal Medicine Quality Control: Current Trends and Analytical Perspective
Fernandes, J. M., Silvestre, C., Zucolotto, S. M., et al. (2025) · Separations · doi:10.3390/separations12110289 · Cited by 7 · see citing works
Garni, H. A. A., Halawany, A. M. E., Koshak, A. E., Malebari, A. M., Alzain, A. A., Mohamed, G. A., Ibrahim, S. R. M., Sayed, N. S. E., & Abdallah, H. M. (2024) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2024.2352725 · Cited by 7 · see citing works
“There has long been recognition in traditional medicine that certain plants and their components can improve cognitive function and relieve the symptoms of Alzheimer’s disease [5].”
BackgroundHerbal medicines in Alzheimer’s disease and the involvement of gut microbiota
Liu, M., Li, T., Liang, H., & Zhong, P. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1416502 · Cited by 6 · see citing works
Martins-Silva, C., Anderson, C. L., Boyce, A. K. J., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04453-5 · Cited by 5 · see citing works
Queuine as a potential multi-target drug for alzheimer’s disease: insights from protein dynamics
Girgin, M., & Kantarci-Carsibasi, N. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2293262 · Cited by 5 · see citing works
“…there is an urgent need for effective and non-toxic natural-sourced drugs having multi-target activity (Piazzi et al., 2003; Kumar et al., 2017a; Kumar et al., 2018a; Prasasty et al., 2018; Avram et al., 2020; Ahmad et al., 2022; Fernandes et al., 2022; Mirza et al., 2022; Liu et al., 2023).”
Park, J.-K., Kim, H.-G., Lee, J.-S., Joo, J.-H., & Yoo, H.-R. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111644 · Cited by 4 · see citing works
Dietary Supplements and Phytopharmaceuticals for the Management of Cognitive Disorders
Nagori, K., Pradhan, M., Nakhate, K. T., Thakur, A., Patle, K., & Thakur, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-63677-6_9 · Cited by 5 · see citing works
Fenugreek: New Therapeutic Resource or Emerging Allergen?
Alessandrello, C., Sanfilippo, S., Gangemi, S., et al. (2024) · Applied Sciences · doi:10.3390/app14209195 · Cited by 4 · see citing works
Bosco, R. B. D., Christyraj, J. R. S. S., & Yesudhason, B. V. (2024) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241307019 · Cited by 5 · see citing works
Huang, S., Huang, Y., Yang, S., et al. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230330105251 · Cited by 4 · see citing works
Abdulkadir, T. S., & Ayo, J. O. (2024) · Comparative Clinical Pathology · doi:10.1007/s00580-024-03603-4 · Cited by 3 · see citing works
“Consumption of exogenous sources of antioxidants exerts beneficial effects on the sus-tenance of the body’s antioxidant defence (Fernandes et al. 2022).”
Zeng, Y., Yang, S., Xie, Z., Li, Q., Wang, Y., Xiong, Q., Liang, X., Lu, H., & Cheng, W. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156542 · Cited by 3 · see citing works
Wu, Y., Zhong, J., Wang, J., Li, H., Chen, X., Xia, X., & Zhou, J. (2024) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2024.06.003 · Cited by 3 · see citing works
Wen, W., Chen, J., Xiang, J., Zhang, S., Liu, J., Wang, J., Wang, P., & Xu, S. (2025) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(25)60927-7 · Cited by 3 · see citing works
Turmeric and Alzheimer’s Disease: Therapeutic Effects of Curcuminoids, Curcumin, and Turmerone
Barbosa, C. D. O., & Neto, J. F. C. (2023) · Springer eBooks · doi:10.1007/978-981-99-7731-4_8 · Cited by 1 · see citing works
Alkhammash, A., Alotaibi, G., Algethami, A., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178231 · Cited by 1 · see citing works
Ilieva, Y. E., Zaharieva, M. M., Dimitrova, L. L., Kaleva, M. D., Marinov, T., Dobreva, L. I., Kim, T. C., Kokanova-Nedialkova, Z. K., Trayanov, I. I., Titorenkova, S., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18101591 · Cited by 1 · see citing works
Peng, Z., Li, Y., Sun, N., et al. (2026) · Phytotherapy Research · doi:10.1002/ptr.70222 · Cited by 1 · see citing works
“These active compounds have been reported to modulate multiple signaling pathways, including Akt and JAK–STAT, to suppress inflammatory responses through immune system regulation (Fernandes et al. 2022).”
Begum, A., Ramu, S., Sundar, L. M., Raj, B., Rawal, P., & Ashok, P. (2025) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2025.100669 · Cited by 2 · see citing works
Lamas, M., Silva, A. M., Moreira, M. M., Maia, M. L., Domingues, V. F., Delerue-Matos, C. M., Amaral, M. H., Fernandes, V. C., & Rodrigues, F. (2024) · Antioxidants · doi:10.3390/antiox13101152
Self-citationEVALUATION OF THE THERAPEUTIC EFFECTS OF SALVIA ROSMARINUS ESSENTIAL OIL ON NERVOUS SYSTEM DISORDERS
Visternicu, M., Rarinca, V., Burlui, V., et al. (2025) · Journal of Experimental and Molecular Biology · doi:10.47743/jemb-2025-214
“The progression of cognitive decline in AD can also be influenced by other factors, such as neuroinflammation and oxidative stress, with the primary source of reactive oxygen species (ROS) being the electron transport chain in the inner mitochondrial membrane (Fernandes et al. 2022).”
Ella, F. A., Ambamba, B. D. A., Njayou, F. N., et al. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.08.007
Supportivmedizin, Multimorbidität und Phytotherapie
Saller, R., & Cero, M. D. (2022) · Zeitschrift für Phytotherapie · doi:10.1055/s-0042-1749466
Ożarowski, M., Karpiński, T. M. M., STYSZYŃSKI, F., URBANIAK, A., Grzywna, W. P., Chaves, D. S. D. A., & Seremak‐Mrozikiewicz, A. (2026) · Herba Polonica · doi:10.5604/01.3001.0055.7332
Zhang, Y., Liu, X., Liu, C., Chen, B., & Junbo, C. (2026) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2026.100825
Kanubaddi, K. R., Yaung, C.-L., Harn, H., Chiou, T., Hsu, S.-X., Wijaya, I., Lin, S.-Z., & Wei, W. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125273
“Modern studies increasingly describe such medicines as “multi-component, multi-target, multi-pathway” therapeutics, and many reports suggest that they can modulate aging-related processes through coordinated effects on inflammation, oxidative injury, metabolism, and stress-response pathways [10–12].”
Krishnappa, G., Aouti, S., Sreedevi, S., Sridhar, A., Murugesan, K., Srinivasan, R., Gothe, S., Kumar, S., Gokulakrishnan, K., Bharath, M. M. S., et al. (2026) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-026-05821-8
Yiganbaierdi, M., Abula, A., Tuerxun, A., Wang, M., Hou, X., Xue, Q., Liang, R., & Guo, Z. (2026) · In Silico Pharmacology · doi:10.1007/s40203-026-00718-0
“QSC, composed of seven medicinal herbs (Xuejie, Quanshen, Gancaogao, Machixianzi, Tanxiang, Zitanxiang and Shiliupi), exhibits multi–component, multi–target, and multi–pathway characteristics, and is therefore more effective than single–target drugs for complex diseases (Fernandes et al. 2022).”
- Authors
- Fernandes, F., Barroso, M. F., De Simone, A., Emriková, E., Dias-Teixeira, M., Pereira, J. P., Chlebek, J., Fernandes, V. C., Rodrigues, F., Andrisano, V., Delerue-Matos, C., & Grosso, C.
- Affiliations
- Rede de Química e Tecnologia (PT)
- University of Bologna (IT)
- Escola Superior de Saúde Ribeiro Sanches (PT)
- Charles University (CZ)
- Universidade Técnica do Porto (PT)
- Corresponding author
- Grosso, Clara
- ORCID
- Venue
- Journal of Ethnopharmacology
- Publisher
- Elsevier BV
- Published
- 2022-05
- Volume
- 290
- Pages
- 115107
- ISSN
- 0378-8741 (ISSN-L)
- OpenAlex
- W4213306104
- Semantic Scholar
- 5dd4df9076f986497bf818aa3c9b3d12680b0810
- Cited by
- 45
- References
- 88
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 16 · 2023: 10 · 2022: 4
- FWCI
- 10.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Ethnopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by-nc-nd)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by-nc-nd)
- Funders
- Ministério da Ciência, Tecnologia e Ensino Superior (UIDB 50006/2020, UIDP/50006/2020, CEECIND/03436/2020)
- Fundação para a Ciência e a Tecnologia (CEECIND/03436/2020, UIDP/50006/2020, MTS/SAS/0077/2020, CEECIND/03107/2020, SFRH/BPD/109153/2015, CEECIND/01886/2020, UIDB/50006/2020)
- Topics
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Complementary and alternative medicine › Ginkgo biloba and Cashew Applications
- Keywords
- Alzheimer's disease, neuroprotection, traditional medicinal plants, herbal decoction, Scutellaria baicalensis, Ginkgo biloba, Hypericum perforatum, turmeric, Lavandula angustifolia, fenugreek, Rosmarinus officinalis, cholinesterase inhibition, glycogen synthase kinase-3β inhibition, antioxidant activity, flavonoids, phenolic acids, curcuminoids, pesticide residues, cytotoxicity, brain endothelial cells, motor neurons
- MeSH terms
- Alzheimer Disease, Cell Line, Cell Survival, Cholinesterases, Dose-Response Relationship, Drug, Glycogen Synthase, Humans, Medicine, Chinese Traditional, Pesticide Residues, Plant Extracts, Plants, Medicinal, Free Radical Scavengers, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review